Nafiseh Shokri-Mashhadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Nafiseh Shokri-Mashhadi has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Hossein Rouhani
Nutrition and Food Security Research Center and Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
3 shared publications - Sabrina Schlesinger
Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
3 shared publications Saeed Saadat
Faculty of Mathematics and Natural Sciences, Heinrich Heine Universität, Düsseldorf, Department of computer sciences, Germany
3 shared publications- Christina Bächle
Institute for Biometrics and Epidemiology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
2 shared publications Fatemeh Navab
Nutrition and Food Security Research Center and Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
2 shared publications- Hamed Mohammadi
Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 27 March 2026
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 42 (4) , e70160
Reassessment of the Diagnostic Accuracy of HbA 1c and Glucose for Type 2 Diabetes: A Systematic Review and Meta‐Analysis of Observational Studies
Aims: This systematic review and meta‐analysis evaluated the diagnostic performance of HbA 1c , fasting plasma glucose (FPG), and 1‐h plasma glucose (1hPG) against the 2‐h plasma glucose standard (≥ 11.1 mmol/L) in adults without previously diagnosed diabetes. Methods: A comprehensive search of Medline and CENTRAL (until 09.2025) identified population‐based studies considering all available cutoff values for these markers. Diagnostic accuracy was estimated using bivariate random‐effects models. Summary ROC curves and optimal cutoff values were derived using a Weibull accelerated failure time approach and the Youden index. Subgroup analyses explored potential differences across continents. The certainty of evidence (CoE) was evaluated using the GRADE approach. Results: Fifty‐eight studies including 276,203 participants were synthesised. Overall, FPG showed higher diagnostic accuracy than HbA 1c , with an optimal cutoff of 6.3 mmol/L [95% confidence interval 6.0 mmol/L; 6.5 mmol/L], yielding 73% [68%; 78%] sensitivity and 91% [89%; 94%] specificity. The optimal HbA 1c cutoff was 47 [42; 49] mmol/mol (i.e., 6.5% [6.0%; 6.6%]), with 62% [51%; 80%] sensitivity and 92% [77%; 96%] specificity. The CoE was low. Across all regions, FPG consistently outperformed HbA 1c . Optimal FPG cutoff values ranged from 5.3 mmol/L in North America to 6.5 mmol/L in Asian countries, and from 41 mmol/mol (5.9%) in Asian countries to 45 mmol/mol (6.3%) in North America for HbA 1c . Conclusions: These results suggest that FPG is a more reliable diagnostic marker than HbA 1c and that uniform global thresholds may not fully reflect population‐specific differences. Further high‐quality studies are needed to refine diagnostic performance and examine factors influencing accuracy.
- 27 March 2026
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 42 (4) , e70160
Open AccessReassessment of the Diagnostic Accuracy of HbA 1c and Glucose for Type 2 Diabetes: A Systematic Review and Meta‐Analysis of Observational Studies
Aims: This systematic review and meta‐analysis evaluated the diagnostic performance of HbA 1c , fasting plasma glucose (FPG), and 1‐h plasma glucose (1hPG) against the 2‐h plasma glucose standard (≥ 11.1 mmol/L) in adults without previously diagnosed diabetes. Methods: A comprehensive search of Medline and CENTRAL (until 09.2025) identified population‐based studies considering all available cutoff values for these markers. Diagnostic accuracy was estimated using bivariate random‐effects models. Summary ROC curves and optimal cutoff values were derived using a Weibull accelerated failure time approach and the Youden index. Subgroup analyses explored potential differences across continents. The certainty of evidence (CoE) was evaluated using the GRADE approach. Results: Fifty‐eight studies including 276,203 participants were synthesised. Overall, FPG showed higher diagnostic accuracy than HbA 1c , with an optimal cutoff of 6.3 mmol/L [95% confidence interval 6.0 mmol/L; 6.5 mmol/L], yielding 73% [68%; 78%] sensitivity and 91% [89%; 94%] specificity. The optimal HbA 1c cutoff was 47 [42; 49] mmol/mol (i.e., 6.5% [6.0%; 6.6%]), with 62% [51%; 80%] sensitivity and 92% [77%; 96%] specificity. The CoE was low. Across all regions, FPG consistently outperformed HbA 1c . Optimal FPG cutoff values ranged from 5.3 mmol/L in North America to 6.5 mmol/L in Asian countries, and from 41 mmol/mol (5.9%) in Asian countries to 45 mmol/mol (6.3%) in North America for HbA 1c . Conclusions: These results suggest that FPG is a more reliable diagnostic marker than HbA 1c and that uniform global thresholds may not fully reflect population‐specific differences. Further high‐quality studies are needed to refine diagnostic performance and examine factors influencing accuracy.
- Open Access
- 11 April 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 82, 103190
Efficacy of automated insulin delivery systems in people with type 1 diabetes: a systematic review and network meta-analysis of outpatient randomised controlled trials
- 11 April 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 82, 103190
Open AccessEfficacy of automated insulin delivery systems in people with type 1 diabetes: a systematic review and network meta-analysis of outpatient randomised controlled trials
- Open Access
Association between nutritional status, daily nutrition delivery and clinical outcomes of critically ill adult patients admitted to the intensive care unit: a protocol for Isfahan multicentre prospective observational cohort ICU study (the Isfahan-ICU study)
Introduction There is currently limited information regarding the association between the modified Nutrition Risk in Critically Ill (mNUTRIC) score, nutrition delivery and clinical outcomes in critically ill patients admitted to the intensive care unit (ICU) section. Methods and analysis The Isfahan-ICU study is a multicentre, prospective observational cohort study that will be conducted on critically ill adults treated in the trauma or medical ICU sections of six hospitals to investigate whether clinical outcomes, including length of ICU stay and 30-day survival, vary by the mNUTRIC score at admission or the 7-day nutrition delivery. This paper outlines the Isfahan-ICU study protocol approved by the ethics committee of Isfahan University of Medical Sciences, Iran. Patient confidentiality is ensured, and study results will be shared at conferences and in medical papers. Ethics and dissemination This study protocol was reviewed and approved by the ethics committee of the Isfahan University of Medical Sciences, Isfahan, Iran (IR.MUI.RESEARCH.REC.1401.184). The patient’s identity will be considered confidential and will not be revealed or published under any circumstances; all provisions of laws governing personal data protection will be observed. Patient data recorded in the electronic survey will be documented pseudonymously using de-identified patient ID codes, and authorised staff at each participating site will have access to only their identifiable data. Results from the study will be disseminated at national and international conferences and in medical papers. Trial registration number Ethics committee of the Isfahan University of Medical Sciences, Isfahan, Iran (IR.MUI.RESEARCH.REC.1401.184).
Open AccessAssociation between nutritional status, daily nutrition delivery and clinical outcomes of critically ill adult patients admitted to the intensive care unit: a protocol for Isfahan multicentre prospective observational cohort ICU study (the Isfahan-ICU study)
Introduction There is currently limited information regarding the association between the modified Nutrition Risk in Critically Ill (mNUTRIC) score, nutrition delivery and clinical outcomes in critically ill patients admitted to the intensive care unit (ICU) section. Methods and analysis The Isfahan-ICU study is a multicentre, prospective observational cohort study that will be conducted on critically ill adults treated in the trauma or medical ICU sections of six hospitals to investigate whether clinical outcomes, including length of ICU stay and 30-day survival, vary by the mNUTRIC score at admission or the 7-day nutrition delivery. This paper outlines the Isfahan-ICU study protocol approved by the ethics committee of Isfahan University of Medical Sciences, Iran. Patient confidentiality is ensured, and study results will be shared at conferences and in medical papers. Ethics and dissemination This study protocol was reviewed and approved by the ethics committee of the Isfahan University of Medical Sciences, Isfahan, Iran (IR.MUI.RESEARCH.REC.1401.184). The patient’s identity will be considered confidential and will not be revealed or published under any circumstances; all provisions of laws governing personal data protection will be observed. Patient data recorded in the electronic survey will be documented pseudonymously using de-identified patient ID codes, and authorised staff at each participating site will have access to only their identifiable data. Results from the study will be disseminated at national and international conferences and in medical papers. Trial registration number Ethics committee of the Isfahan University of Medical Sciences, Isfahan, Iran (IR.MUI.RESEARCH.REC.1401.184).
- 26 September 2024
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 79 (2) , 113-125
Effects of carotenoid supplementation on glycemic control: a systematic review and meta-analysis of randomized clinical trials
Objectives We conducted a systematic review and meta-analysis to assess the effects of carotenoid supplementation on glycemic indices, and the certainty of evidence. Methods A systematic literature search in PubMed, SCOPUS, ISI–Web of Science, and Cochrane Library was conducted from inception up to Jun 17, 2024. Randomized controlled trials (RCTs) investigating the effect of carotenoid supplementation on circulating glycemic parameters were included. Records were excluded when studies reported the effect of co-interventions with other nutrients, did not provide mean differences (MDs) and standard deviations (SD) for outcomes, or administered whole food rather than supplements of carotenoids. Summary mean differences (MDs) and 95% CI between intervention and control groups were estimated using a random-effects model. The risk of bias of the included studies was assessed using the Risk of Bias 2.0 (RoB 2.0) tool. Results Overall, 36 publications with 45 estimated effect sizes were included in the meta-analyses. The overall findings showed an improvement in fasting blood glucose (FBG) (MD = −4.54 mg/dl; 95% CI: −5.9, −3.2; n = 45), and hemoglobin A1C (HbA1C) (MD = −0.25% (95% CI: −0.4, −0.11; n = 22) in the intervention group in comparison with the control group. Moreover, in individuals with type 2 diabetes (T2D), interventions with astaxanthin and fucoxanthin led to a reduction in FBG by 4.36 mg/dl (95% CI: −6.13, −2.6; n = 10). The findings also showed that the intervention with crocin reduced FBG levels by 13.5 mg/dl (95% CI: −15.5, −7.8; n = 5), and HbA1C by 0.55% (95% CI: −0.77, −0.34; n = 5) in individuals with T2D. However, the certainty of evidence was very low. Conclusion Carotenoid’s supplementation improved glycemic parameters especially in people with T2D. However. the certainty of evidence was very low, mainly due to small sample size, and indirectness. Therefore, no specific recommendations can be provided at present and well-designed RCTs are required. Registry URL https://www.crd.york.ac.uk/PROSPERO/ Registry number CRD42021285084 Registry and registry number for systematic reviews or meta-analyses PROSPERO ID: CRD42021285084
- 26 September 2024
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 79 (2) , 113-125
Effects of carotenoid supplementation on glycemic control: a systematic review and meta-analysis of randomized clinical trials
Objectives We conducted a systematic review and meta-analysis to assess the effects of carotenoid supplementation on glycemic indices, and the certainty of evidence. Methods A systematic literature search in PubMed, SCOPUS, ISI–Web of Science, and Cochrane Library was conducted from inception up to Jun 17, 2024. Randomized controlled trials (RCTs) investigating the effect of carotenoid supplementation on circulating glycemic parameters were included. Records were excluded when studies reported the effect of co-interventions with other nutrients, did not provide mean differences (MDs) and standard deviations (SD) for outcomes, or administered whole food rather than supplements of carotenoids. Summary mean differences (MDs) and 95% CI between intervention and control groups were estimated using a random-effects model. The risk of bias of the included studies was assessed using the Risk of Bias 2.0 (RoB 2.0) tool. Results Overall, 36 publications with 45 estimated effect sizes were included in the meta-analyses. The overall findings showed an improvement in fasting blood glucose (FBG) (MD = −4.54 mg/dl; 95% CI: −5.9, −3.2; n = 45), and hemoglobin A1C (HbA1C) (MD = −0.25% (95% CI: −0.4, −0.11; n = 22) in the intervention group in comparison with the control group. Moreover, in individuals with type 2 diabetes (T2D), interventions with astaxanthin and fucoxanthin led to a reduction in FBG by 4.36 mg/dl (95% CI: −6.13, −2.6; n = 10). The findings also showed that the intervention with crocin reduced FBG levels by 13.5 mg/dl (95% CI: −15.5, −7.8; n = 5), and HbA1C by 0.55% (95% CI: −0.77, −0.34; n = 5) in individuals with T2D. However, the certainty of evidence was very low. Conclusion Carotenoid’s supplementation improved glycemic parameters especially in people with T2D. However. the certainty of evidence was very low, mainly due to small sample size, and indirectness. Therefore, no specific recommendations can be provided at present and well-designed RCTs are required. Registry URL https://www.crd.york.ac.uk/PROSPERO/ Registry number CRD42021285084 Registry and registry number for systematic reviews or meta-analyses PROSPERO ID: CRD42021285084
- 23 November 2023
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (5) , 2003-2010
Association between major dietary patterns and Parkinson’s disease risk: a case–control study
Background There has been emerging attention to investigate the possible role of some dietary factors in the pathogenesis of Parkinson’s disease (PD); however, evidence about the relationship between dietary components and the risk of PD is limited. The aim of this study was to determine the association between major dietary patterns and the risk of PD. Methods This case–control study was performed on 105 patients with newly diagnosed PD and 215 healthy controls. Diagnosis of Parkinson’s disease was made based on the UK Brain Bank criteria. Usual dietary intakes were collected by a validated semi-quantitative food frequency questionnaire. Dietary patterns were detected by principal component analysis. Results Four dietary patterns, including traditional, healthy, western, and light dietary patterns, were identified. After considering all potential confounders, individuals with the highest tertile of traditional dietary pattern scores had a lower risk of PD than those with the lowest tertile (OR: 0.002; 95% CI: 0.000–0.016). A similar inverse association between the healthy pattern (OR: 0.314; 95% CI: 0.131–0.750) and light pattern (OR: 0.282; 95% CI: 0.121–0.654) and risk of PD was revealed. In contrast, adherence to the western dietary pattern was associated with PD incidence (OR: 7.26; 95% CI: 2.76–19.09). Conclusions The findings of this study suggest that adherence to western dietary pattern could increase the risk of PD by approximately seven times. However, the traditional, healthy, and light dietary patterns had an inverse relationship with PD risk.
- 23 November 2023
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (5) , 2003-2010
Association between major dietary patterns and Parkinson’s disease risk: a case–control study
Background There has been emerging attention to investigate the possible role of some dietary factors in the pathogenesis of Parkinson’s disease (PD); however, evidence about the relationship between dietary components and the risk of PD is limited. The aim of this study was to determine the association between major dietary patterns and the risk of PD. Methods This case–control study was performed on 105 patients with newly diagnosed PD and 215 healthy controls. Diagnosis of Parkinson’s disease was made based on the UK Brain Bank criteria. Usual dietary intakes were collected by a validated semi-quantitative food frequency questionnaire. Dietary patterns were detected by principal component analysis. Results Four dietary patterns, including traditional, healthy, western, and light dietary patterns, were identified. After considering all potential confounders, individuals with the highest tertile of traditional dietary pattern scores had a lower risk of PD than those with the lowest tertile (OR: 0.002; 95% CI: 0.000–0.016). A similar inverse association between the healthy pattern (OR: 0.314; 95% CI: 0.131–0.750) and light pattern (OR: 0.282; 95% CI: 0.121–0.654) and risk of PD was revealed. In contrast, adherence to the western dietary pattern was associated with PD incidence (OR: 7.26; 95% CI: 2.76–19.09). Conclusions The findings of this study suggest that adherence to western dietary pattern could increase the risk of PD by approximately seven times. However, the traditional, healthy, and light dietary patterns had an inverse relationship with PD risk.
- Open Access
- 26 July 2023
- Published by IntechOpen
Perspective Chapter: The Role of Modifiable Factors, Particularly Nutritional Factors, on Age-Related Sarcopenia
Advances in medicine result in an increase in the age of global population. The percentage of people over 60 years will approximately be duplicated up to 22 between 2015 and 2050, which is associated with a notable rise in age-related complications such as sarcopenia and frailty. The age-related sarcopenia is defined by low muscle strength, and it is considered severe if low muscle strength, low muscle mass, and low physical performance are detected.This condition is associated with poor quality of life, risk of falls, fractures, and higher healthcare costs. Despite the growing interest regarding the treatment of this phenomenon, the lack of adequate knowledge underlying the multifactorial parthenogenesis of age-related sarcopenia hinders the diagnosis of effective therapeutic approaches. In this respect, one of the major solutions would be to recognize the effect of modifiable factors on muscle health during the lifetime. Previous observations indicated that dietary and nutritional factors, beyond other environmental agents across the life course are related to muscle mass and function in the elderly. With respect to the fundamental role of nutrients with antioxidants properties in maintaining many aspects of health, this chapter aims to discuss the association between components of sarcopenia and nutritional status in older adults, and their potential effect on prevention and treatment of age-related sarcopenia.
- 26 July 2023
- Published by IntechOpen
Open AccessPerspective Chapter: The Role of Modifiable Factors, Particularly Nutritional Factors, on Age-Related Sarcopenia
Advances in medicine result in an increase in the age of global population. The percentage of people over 60 years will approximately be duplicated up to 22 between 2015 and 2050, which is associated with a notable rise in age-related complications such as sarcopenia and frailty. The age-related sarcopenia is defined by low muscle strength, and it is considered severe if low muscle strength, low muscle mass, and low physical performance are detected.This condition is associated with poor quality of life, risk of falls, fractures, and higher healthcare costs. Despite the growing interest regarding the treatment of this phenomenon, the lack of adequate knowledge underlying the multifactorial parthenogenesis of age-related sarcopenia hinders the diagnosis of effective therapeutic approaches. In this respect, one of the major solutions would be to recognize the effect of modifiable factors on muscle health during the lifetime. Previous observations indicated that dietary and nutritional factors, beyond other environmental agents across the life course are related to muscle mass and function in the elderly. With respect to the fundamental role of nutrients with antioxidants properties in maintaining many aspects of health, this chapter aims to discuss the association between components of sarcopenia and nutritional status in older adults, and their potential effect on prevention and treatment of age-related sarcopenia.
- 3 November 2022
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 164, 106691
The effect of lutein and Zeaxanthine on dyslipidemia: A meta-analysis study
- 3 November 2022
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 164, 106691
The effect of lutein and Zeaxanthine on dyslipidemia: A meta-analysis study
- Open Access
- 17 February 2022
- Published by Springer Nature in Journal of Intensive Care
- Vol. 10 (1) , 1-16
Is it time to reconsider the administration of thiamine alone or in combination with vitamin C in critically ill patients? A meta-analysis of clinical trial studies
Background: Although the effect of thiamine alone or in combination with vitamin C has been studied in multiple trials (RCT and interventional studies), their results are inconsistent. This meta-analysis aimed to assess impact of thiamine administration alone, thiamine in combination with vitamin C, and co-administration of low-dose hydrocortisone, vitamin C and thiamine (HVT) on clinical outcomes in critically ill patients.Methods and materials: After electronic searches on PubMed, Scopus, Cochrane Library, and Web of Science databases, initially 3367 papers were found, and 20 interventional studies were included in our analysis. We assessed the risk-difference between treatment and control (standard treatment) groups by pooling available data on ICU length of stay, number of ventilator free days, mortality, and changes in Sequential Organ Failure Assessment (SOFA) scores.Results: The results of present studies revealed no significant effect of thiamine in combination with vitamin C, and HVT on number of free days of ventilation. Thiamine alone supplementation was associated with high mortality percentage (WMD: 5.17%; 95% CI: 2.67, 7.67). Thiamine in combination with vitamin C had no significant impact on mortality rate. In contrast, HVT could decrease mortality rate (WMD: − 7.23%; 95% CI: − 10.31, − 4.16; I-square: 0.0%). There was no significant effect of thiamine alone, co-administration of thiamine and vitamin C, and HVT on ICU length of stay. The results of the meta-analysis showed that thiamine alone and HVT supplementation had no significant effect on SOFA score. Interestingly, co-supplementation of thiamine and vitamin C had a significant decreasing effect on SOFA score (WMD: − 0.73; 95% CI: − 1.29, − 0.17; I-square: 0.0%).Conclusion: In contrast to HVT, thiamine supplementation alone was associated with increased mortality rate in ICU. However, co-supplementation of thiamine and vitamin C had a significant decreasing effect on SOFA score.
- 17 February 2022
- Published by Springer Nature in Journal of Intensive Care
- Vol. 10 (1) , 1-16
Open AccessIs it time to reconsider the administration of thiamine alone or in combination with vitamin C in critically ill patients? A meta-analysis of clinical trial studies
Background: Although the effect of thiamine alone or in combination with vitamin C has been studied in multiple trials (RCT and interventional studies), their results are inconsistent. This meta-analysis aimed to assess impact of thiamine administration alone, thiamine in combination with vitamin C, and co-administration of low-dose hydrocortisone, vitamin C and thiamine (HVT) on clinical outcomes in critically ill patients.Methods and materials: After electronic searches on PubMed, Scopus, Cochrane Library, and Web of Science databases, initially 3367 papers were found, and 20 interventional studies were included in our analysis. We assessed the risk-difference between treatment and control (standard treatment) groups by pooling available data on ICU length of stay, number of ventilator free days, mortality, and changes in Sequential Organ Failure Assessment (SOFA) scores.Results: The results of present studies revealed no significant effect of thiamine in combination with vitamin C, and HVT on number of free days of ventilation. Thiamine alone supplementation was associated with high mortality percentage (WMD: 5.17%; 95% CI: 2.67, 7.67). Thiamine in combination with vitamin C had no significant impact on mortality rate. In contrast, HVT could decrease mortality rate (WMD: − 7.23%; 95% CI: − 10.31, − 4.16; I-square: 0.0%). There was no significant effect of thiamine alone, co-administration of thiamine and vitamin C, and HVT on ICU length of stay. The results of the meta-analysis showed that thiamine alone and HVT supplementation had no significant effect on SOFA score. Interestingly, co-supplementation of thiamine and vitamin C had a significant decreasing effect on SOFA score (WMD: − 0.73; 95% CI: − 1.29, − 0.17; I-square: 0.0%).Conclusion: In contrast to HVT, thiamine supplementation alone was associated with increased mortality rate in ICU. However, co-supplementation of thiamine and vitamin C had a significant decreasing effect on SOFA score.
- Open Access
- 29 December 2021
- Published by Springer Nature in Research Square
A Systematic Review and Meta-analysis of Effect of Probiotic Supplementation on Age-related Sarcopenia in Elderly Adults
Background: Several clinical studies emphasized the role of bio-diversities of gut microbiota in age-related disorders. Nevertheless, the effect of probiotic administration on sarcopenia indices are unclear. This meta-analysis aimed to investigate the effect of probiotic administration on muscle strength, muscle mass, and muscle function. Methods: We assessed all interventional studies through different electronic databases including PubMed, Scopus, ISI –Web of Science, and Cochrane library using defined keywords from inception to Jun 2021. Studies that investigated the effect of probiotic administration on at least one of the components of sarcopenia or anthropometric indices versus non- probiotics in old adults (>55 years) were included. Results: The initially overall effect of meta-analysis on 1393 participants declared a null effect of probiotic supplementation on main outcomes, including muscle mass (WMD: -0.05, 95% CI: -1.54, 1.43; I-square: 0.0%, P=0.985), and muscle strength (WMD: 0.7, 95% CI: -0.01, 1.40; I-square: 76.8%, P=0.005). Subgroup analysis showed that administration of probiotic supplementation for more than 12 weeks significantly increased muscle strength (WMD: 1.15, 95% CI: 0.86, 1.43; I-square: 0.0%, P=0.679). However, probiotic supplementation had no effect on anthropometric indices, including body mass and body mass index, (WMD: -0.05, 95% CI:-2.57, 1.56; I-square: 0.0%, P=0.976) and (WMD: 0.08, 95% CI:-0.16, 0.32; I-square: 0.0%, P=0.718), respectively. Conclusion: This study confirmed the positive impact of probiotic supplementation on the muscle strength (based on the last definitions by EWGSOP), in particular, probiotic administration for more than 12 weeks. More clinical trials on sarcopenic elderly subjects are wanted to confirm our findings.
- 29 December 2021
- Published by Springer Nature in Research Square
Open AccessA Systematic Review and Meta-analysis of Effect of Probiotic Supplementation on Age-related Sarcopenia in Elderly Adults
Background: Several clinical studies emphasized the role of bio-diversities of gut microbiota in age-related disorders. Nevertheless, the effect of probiotic administration on sarcopenia indices are unclear. This meta-analysis aimed to investigate the effect of probiotic administration on muscle strength, muscle mass, and muscle function. Methods: We assessed all interventional studies through different electronic databases including PubMed, Scopus, ISI –Web of Science, and Cochrane library using defined keywords from inception to Jun 2021. Studies that investigated the effect of probiotic administration on at least one of the components of sarcopenia or anthropometric indices versus non- probiotics in old adults (>55 years) were included. Results: The initially overall effect of meta-analysis on 1393 participants declared a null effect of probiotic supplementation on main outcomes, including muscle mass (WMD: -0.05, 95% CI: -1.54, 1.43; I-square: 0.0%, P=0.985), and muscle strength (WMD: 0.7, 95% CI: -0.01, 1.40; I-square: 76.8%, P=0.005). Subgroup analysis showed that administration of probiotic supplementation for more than 12 weeks significantly increased muscle strength (WMD: 1.15, 95% CI: 0.86, 1.43; I-square: 0.0%, P=0.679). However, probiotic supplementation had no effect on anthropometric indices, including body mass and body mass index, (WMD: -0.05, 95% CI:-2.57, 1.56; I-square: 0.0%, P=0.976) and (WMD: 0.08, 95% CI:-0.16, 0.32; I-square: 0.0%, P=0.718), respectively. Conclusion: This study confirmed the positive impact of probiotic supplementation on the muscle strength (based on the last definitions by EWGSOP), in particular, probiotic administration for more than 12 weeks. More clinical trials on sarcopenic elderly subjects are wanted to confirm our findings.
- 15 December 2021
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 13 (1) , 451-453
Comment on “The association between carotenoids and subjects with overweight or obesity: a systematic review and meta-analysis” by N. Yao, S. Yan, Y. Guo, H. Wang, X. Li, L. Wang, W. Hu, B. Li and W. Cui, Food Funct., 2021, 12, 4768.
The association between carotenoids and subjects with overweight or obesity: reanalysis is needed.
- 15 December 2021
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 13 (1) , 451-453
Comment on “The association between carotenoids and subjects with overweight or obesity: a systematic review and meta-analysis” by N. Yao, S. Yan, Y. Guo, H. Wang, X. Li, L. Wang, W. Hu, B. Li and W. Cui, Food Funct., 2021, 12, 4768.
The association between carotenoids and subjects with overweight or obesity: reanalysis is needed.